We are live on ! Find out more
JY

Jeff Yass Susquehanna International Group

AUM $1.28T
1-Year Est. Return 58.89%
 

Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.

This Fund
S&P 500
This Quarter Est. Return
-3.2%
1 Year Est. Return
+58.89%
3 Year Est. Return
+161.44%
5 Year Est. Return
+153.95%
10 Year Est. Return
+545.54%
AUM
$745B
AUM Growth
+$33.9B
Cap. Flow
-$10.6B
Cap. Flow %
-1.43%
Top 10 Hldgs %
31.69%
Holding
14,193
New
1,741
Increased
5,205
Reduced
5,319
Closed
1,559

Top Sells

Rank Stock Value
1
DIS icon
Walt Disney
DIS
+$2.17B
2
AMZN icon
Amazon
AMZN
+$1.98B
3
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$1.79B
4
NVDA icon
NVIDIA
NVDA
+$1.18B
5
WFC icon
Wells Fargo
WFC
+$827M

Sector Composition

Rank Sector Weight
1 Miscellaneous 92.63%
2 Technology 1.89%
3 Consumer Discretionary 1.29%
4 Communication Services 0.93%
5 Healthcare 0.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BICK
10251
DELISTED
First Trust BICK Index Fund
BICK
$338K ﹤0.01%
+9,958
New +$367K
AUTL
10252
CALL
Autolus Therapeutics
AUTL
$623M
$337K ﹤0.01%
+51,500
New +$325K
BKF icon
10253
PUT
iShares MSCI BIC ETF
BKF
$75.3M
$337K ﹤0.01%
+7,000
New +$350K
STEX
10254
Streamex Corp
STEX
$89.9M
$337K ﹤0.01%
11,323
-3,315
-23% -$108K
SCHM icon
10255
CALL
Schwab US Mid-Cap ETF
SCHM
$14.9B
$337K ﹤0.01%
13,200
+3,600
+38% +$94.1K
OLOX
10256
CALL
Olenox Industries
OLOX
$1.81M
$337K ﹤0.01%
17
-32
-65% -$768K
ACWI icon
10257
iShares MSCI ACWI ETF
ACWI
$33.3B
$336K ﹤0.01%
3,362
-370,920
-99% -$38.1M
BDTX icon
10258
PUT
Black Diamond Therapeutics
BDTX
$128M
$336K ﹤0.01%
39,700
+2,900
+8% +$28.6K
BIO.B icon
10259
Bio-Rad Laboratories Class B
BIO.B
$336K ﹤0.01%
452
+1
+0.2% +$754
CFFI icon
10260
C&F Financial
CFFI
$298M
$336K ﹤0.01%
+6,320
New +$331K
HIW icon
10261
Highwoods Properties
HIW
$3.44B
$336K ﹤0.01%
7,663
-16,374
-68% -$750K
NERV icon
10262
Minerva Neurosciences
NERV
$231M
$336K ﹤0.01%
24,155
+18,367
+317% +$276K
ZROZ icon
10263
PIMCO 25+ Year Zero Coupon US Treasury Index Exchange-Traded Fund
ZROZ
$1.52B
$336K ﹤0.01%
+2,304
New +$348K
EIGR
10264
PUT
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$336K ﹤0.01%
1,677
+110
+7% +$26.2K
PFHD
10265
DELISTED
Professional Holding Corp. Class A Common stock
PFHD
$336K ﹤0.01%
+17,875
New +$340K
GH icon
10266
Guardant Health
GH
$21.7B
$335K ﹤0.01%
+2,681
New +$319K
IMDX
10267
CALL
Insight Molecular Diagnostics
IMDX
$135M
$335K ﹤0.01%
4,700
+1,045
+29% +$96.1K
ENZ
10268
DELISTED
Enzo Biochem, Inc.
ENZ
$335K ﹤0.01%
94,515
+50,688
+116% +$169K
SVFA
10269
PUT
DELISTED
SVF Investment Corp. Class A Ordinary Shares
SVFA
$335K ﹤0.01%
34,300
+5,000
+17% +$48.9K
DCH
10270
Dauch Corp
DCH
$1.5B
$334K ﹤0.01%
37,869
-158,858
-81% -$1.46M
METC icon
10271
CALL
Ramaco Resources Class A
METC
$843M
$334K ﹤0.01%
+28,010
New +$233K
MRVI icon
10272
Maravai LifeSciences
MRVI
$1.14B
$334K ﹤0.01%
6,809
-6,921
-50% -$338K
NOAH
10273
PUT
Noah Holdings
NOAH
$589M
$334K ﹤0.01%
+9,000
New +$357K
PLX icon
10274
Protalix BioTherapeutics
PLX
$205M
$334K ﹤0.01%
251,171
-31,974
-11% -$48.6K
WTPI
10275
WisdomTree Equity Premium Income Fund
WTPI
$514M
$334K ﹤0.01%
10,267
+3,311
+48% +$107K

Similar funds

Jeff Yass's Q3 2021 Portfolio in Review

As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Jeff Yass's Q3 2021 filing shows 1,741 new, 5,205 increased, 5,319 reduced and 1,559 closed positions. Its largest new stake was InMode: 613,660 shares worth $48.9M. The largest sale was Walt Disney, an estimated $2.17B.

By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 91% a quarter earlier, followed by Technology and Consumer Discretionary.

  • Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
  • Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
  • Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
  • Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
  • Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
  • Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
  • Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.

Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.